Table 2.
Clinical efficacy.
| CR | PR | SD | PD | Overall response rate | |
|---|---|---|---|---|---|
| Control group (n = 65) | 20 (30.8) | 22 (33.8) | 13 (20.0) | 10 (15.4) | 42 (64.6) |
| Combination group (n = 76) | 38 (50.0) | 26 (34.2) | 8 (10.5) | 4 (5.3) | 64 (84.2) |
| χ 2 | 8.8773 | 7.2091 | |||
| P | 0.0310 | 0.0073 |
Clinical efficacy.
| CR | PR | SD | PD | Overall response rate | |
|---|---|---|---|---|---|
| Control group (n = 65) | 20 (30.8) | 22 (33.8) | 13 (20.0) | 10 (15.4) | 42 (64.6) |
| Combination group (n = 76) | 38 (50.0) | 26 (34.2) | 8 (10.5) | 4 (5.3) | 64 (84.2) |
| χ 2 | 8.8773 | 7.2091 | |||
| P | 0.0310 | 0.0073 |